NASDAQ: SAGESage Therapeutics Inc Stock Ownership - Who owns Sage Therapeutics?
Insider buying vs selling
Have Sage Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gregory L. Shiferman | Senior Vice President General Counsel and Secretary | 2024-12-24 | 79 | $5.48 | $432.92Sell |
| Christopher Benecchi | Chief Business Officer | 2024-08-05 | 4,755 | $8.96 | $42.60kSell |
| Anne Marie Cook | SVP GC Secretary | 2024-08-05 | 4,503 | $8.96 | $40.35kSell |
| Laura Gault | Chief Medical Officer | 2024-08-05 | 3,288 | $8.96 | $29.46kSell |
| Barry E. Greene | President and CEO | 2024-08-05 | 12,273 | $8.96 | $109.97kSell |
| Kimi Iguchi | CFO Treasurer | 2024-08-05 | 3,636 | $8.96 | $32.58kSell |
SAGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SAGE insiders and whales buy or sell their stock.
SAGE Shareholders
What type of owners hold Sage Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Steven M. Paul | 12.15% | 7,432,477 | $51.80M | Insider |
| Biogen Inc | 10.20% | 6,241,473 | $43.50M | Insider |
| Vanguard Group Inc | 9.42% | 5,760,449 | $40.15M | Institution |
| Rtw Investments LP | 9.14% | 5,591,700 | $38.97M | Institution |
| Robert Nelsen | 8.96% | 5,482,038 | $38.21M | Insider |
| Blackrock Inc | 8.81% | 5,390,913 | $37.57M | Institution |
| Blackrock Inc 1 | 8.81% | 5,390,913 | $37.57M | Institution |
| Fmr LLC | 8.62% | 5,271,108 | $36.74M | Institution |
| Bellevue Group Ag | 7.29% | 4,460,693 | $31.09M | Institution |
| State Street Corp | 4.78% | 2,926,239 | $20.40M | Institution |
SAGE vs Biotech Stocks
Sage Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.